Jul
19
Thu
ETHICAL CONSIDERATIONS IN THE FACE OF AN OPIOID CRISIS- Save the Date: July 19, 2018 @ MAHEC Blue Ridge Room
Jul 19 @ 8:15 am – 4:00 pm

SAVE THE DATE!! JULY 19, 2018

More information to come. Please check back! 

The Opioid Crisis has reached a critical point. Providers in healthcare are faced with regulations and emerging new trends in best practices nearly every day. They are faced with the ethical dilemma of what is the best treatment approach for caring for their patients. This conference aims to address the ethical considerations of the Opioid Crisis and what providers can do to ensure that their patients are achieving the best possible outcomes.

Some of the topics we’ll cover are the ethics surrounding pregnancy, neonatal abstinence syndrome, infectious disease, and bias. North Carolina Attorney General, Josh Stein, will provide the Keynote Address and discuss the ethics of the North Carolina response to the Opioid Crisis. Stein has made combatting the opioid crisis a top priority. His office drafted the STOP Act to reduce the number of people who become addicted to opioids through smarter prescribing practices and the Synthetic Opioid Control Act to close loopholes in state criminal law concerning fentanyl. Both laws passed the General Assembly unanimously and were signed into law by the Governor.

Sep
5
Wed
Recovery Within Reach: Building Team Expertise in Office-Based Opioid Treatment (OBOT) @ Foundation Auditorium
Sep 5 @ 8:30 am – 12:45 pm

Opioid addiction is a chronic, relapsing brain disease that affects millions of Americans and produces a tremendous burden on the healthcare system. In 2002, U.S. physicians gained the opportunity to treat opioid-addicted patients with buprenorphine in primary care settings, commonly referred to as office-based opioid treatment (OBOT). OBOT has been shown to be effective in primary care settings and impacts public health through the reduction of opioid use, opioid overdose mortality, and transmission of infectious diseases. However, it remains underutilized.

One consistently cited barrier preventing OBOT expansion is lack of adequate clinical support given the additional needs for patient monitoring. Successful medication-assisted treatment (MAT) requires a team-based approach just like treatment for other chronic diseases. In addition, treatment is more effective when providers can use a trauma-informed and gender-responsive treatment plan.

The goal of this companion program to the AAAP Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders (the “Half and Half” Course) is to increase the comfort level and expertise of the healthcare team by outlining a team approach, trauma-informed interventions, gender-responsive care, and making recommendations for the implementation of buprenorphine OBOT.

Location
Please note: This conference is being held at the NC Medical Society Foundation Auditorium on 222 N. Person Street in Raleigh, NC 27601.
 For a map to the NC Medical Society, please click here. 

If you are a prescriber in primary care, emergency medicine, pain management, psychiatric, HIV and addiction medicine, you may interested in “Physicians’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course on the same date.

By registering for this conference, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

Objectives

  • Describe the presented framework of office-based opioid treatment (OBOT) including practice changes, medications used, psychosocial services, and integration/coordination components
  • Utilize evidence-based interventions that are trauma-informed and gender-responsive to treat persons with substance use disorders
  • Define the roles of an effective practice team, including primary care and behavioral health clinicians, working together with patients and families, and using a systematic and cost-effective approach to provide patient-centered care for opioid and other substance use disorders
  • Increase medical and behavioral health professionals’ receptivity and capability to work collaboratively as they evaluate and manage opioid and other substance use disorders using SBIRT (screening, brief intervention and referral to treatment)
  • List key components of evidence-based and effective OBOT

Click here to be taken to registration

Click here for a program brochure

Providers’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course @ Foundation Auditorium
Sep 5 @ 9:00 pm – 10:00 pm

Description

Opioid dependence is epidemic in the United States. While progress has been made in training providers, the gap in providing effective treatment of opioid use disorders continues to widen, moving beyond heroin addicted individuals to a much larger and diverse segment of the population. This increase is predominantly due to an alarming increase in addiction to prescription opioid analgesic medications.

Buprenorphine, the most recent addition to the pharmacotherapies available to treat opioid dependence, is novel among the opioid pharmacotherapies because of its partial agonist properties. It has been placed on Schedule III and is available by prescription from a physician’s office-based practice.

Recognizing the impact of this addiction, as well as learning how to treat opioid use disorders, are important steps in combating this ever growing medical problem. To obtain the waiver to prescribe, providers are required to take specialized training. PCSS-MAT uses the Half-and-Half format (first, 4.25 hours of face-to-face training with an instructor, followed by 3.75 hours of on-your-own-training that must be completed along with a post test). This training meets the requirements for physicians; however additional training is required for advanced practice providers.

The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. Once the waiver training is completed in full, participants will receive a CME certificate of attendance from AAAP.

See brochure for complete information on credits.

By registering for this conference, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

The program is recommended for prescribers in primary care, emergency medicine, pain management, psychiatric, HIV, and addiction medicine. (Not a prescriber? CLICK HERE)

Objectives

  • Define the federal Drug Abuse Treatment Act (DATA) of 2000 and the subsequent revisions that lists the criteria needed for Office-Based Opioid Treatment (OBOT)
  • List the criteria for establishing the diagnosis of opioid dependence
  • Distinguish between spontaneous withdrawal and precipitated withdrawal as well as the appropriate methods of buprenorphine induction
  • Describe and contrast the functions of full mu agonists, partial agonists, and antagonists
  • Explain the interplay between pain and addiction, and how buprenorphine can be used to help stabilize these patients
  • Describe the basic approach used in at least three different types of non-pharmacological treatment of opioid dependence
  • Describe three symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder
  • Describe at least three factors to consider in determining if the patient is an appropriate candidate for office-based treatment with buprenorphine
  • Describe at least three areas that should be covered in the rules and expectations communicated to patients during the patient assessment process
  • List at least three situations in which patient information, with patient identity, can be shared under current laws protecting the patient’s confidentiality 42 CFR and HIPAA
  • Reduce and minimize buprenorphine misuse and diversion
  • Describe the drug interactions of buprenorphine and pediatric exposures

Click here for a brochure

Click here for registration

Sep
13
Thu
Treatment Options for Opioid Use Disorder and Co-Occurring Disorders @ Hopeway Foundation
Sep 13 @ 8:30 am – 12:45 pm

This conference is Jointly Provided by Charlotte AHEC and HopeWay Foundation. 

•11.8 million people misuse opioids and 2.1 million Americans suffer from opioid use disorder (SAMHSA)
•66% of the drug overdose deaths in 2016 were from opioids (SAMHSA)
•Over 40% of opioid dependent individuals have co-occurring psychiatric disorders (buppractice.com)

The U.S. Department of Health and Human Services states that in addition to better pain management options and better targeting of overdose reversing drugs, we need better prevention, treatment, and recovery services. This workshop will discuss counseling and behavioral therapy strategies, as well as the current accepted medication-assisted treatments.

Faculty
Dr. Alyson Kuroski-Mazzei, DO, MRO, FAPA
Dr. Kevin Marra, MD
Yvonne Carrasco, MSW, LCAS, MAC
HopeWay Foundation

Objectives

  • Identify symptoms suggesting an opioid use disorder
  • Explore 3 medication–assisted treatments: Methadone, Buprenorphine, Naltrexone
  • Summarize 4 psychiatric disorders commonly occurring with opioid use disorder: major depressive disorder, generalized anxiety disorder, bipolar affective disorder, post-traumatic stress disorder
  • Analyze medical comorbidities associated with opioid use disorder
  • Establish what substance use and mental health recovery have in common

Click here for registration

Sep
14
Fri
New Issues for a New Age: Wake AHEC Substance Use Treatment Conference @ William F. Andrews Conference Center
Sep 14 @ 8:30 am – 4:15 pm

This conference is will explore substance use trends and current issues in North Carolina as well as discuss specific evidence based treatments and considerations when working with this population. Morning sessions will assist professionals in learning how to operate successfully in a managed care world and address changes with integrated healthcare and Medicaid reform. Participants will also hear about new programs in the substance use field. Afternoon sessions will focus more on substance use among specific populations and review interventions for working with these groups. Professionals will learn skills to enhance their practice and stay up to date on substance use treatment in the modern world.

$85 early registration fee. $105 after August 31. $30 cancellation fee. No refunds will be issued unless we are notified by 5 pm Tuesday, September 11, 2018. A $30 cancellation fee will be deducted from your registration fee if a refund is issued. Substitutes are encouraged.

Click here for a program brochure

Sep
21
Fri
Southern Pain Society 32nd Annual Meeting: ‘Balanced Approaches to Acute and Chronic Pain’ @ Sheraton Atlanta Hotel
Sep 21 @ 2:00 pm – Sep 23 @ 12:00 pm

19ME005 - Southern Pain Society 32nd Annual Meeting: 'Balanced Approaches to Acute and Chronic Pain'

The 32nd Annual Meeting of the Southern Pain Society will explore the benefits, challenges and education involved in using a balance integrative approach to managing both acute and chronic pain and how these impact health care professionals.

The Southern Pain Society (SPS) was established in 1986 as a regional section of the American Pain Society and endorses and supports the mission
and goals of the American Pain Society. The Southern Pain Society’s missions are to serve people with pain by advancing research and treatment and to increase the knowledge and skill of the regional professional community. Visit www.southernpainsociety.org to join and take advantage of the
discounted registration fee.

Objectives

  • Discuss the unintended consequences of the current CDC Opioid Guidelines
  • Explain advanced techniques in neuromodulation, surgical and procedural modalities for chronic pain
  • Identify at least two innovative therapies, medications and procedures for the treatment of acute and chronic pain
  • Explain how pain of a catastrophic injury can be effectively managed using an integrative approach through the continuum
  • Identify opiate prescribing deterrent formulations to reduce opioid dependence

Click here to be taken to registration: Early registration is from 2/15 – 9/14

Click here for a program brochure

 

Sep
26
Wed
2018 North Carolina Drug User Health Summit @ Blue Ridge Room
Sep 26 @ 9:00 am – 4:30 pm

This one-day program will focus on treating the active drug user in a compassionate and comprehensive way. This summit will include training in harm reduction, the infectious implications of drug use, engaging drug using patients in care, and integrated care in patients who use drugs. Local, state and national experts in drug user health will be featured.

Lodging

Book your overnight accommodations at the Marriott Renaissance Asheville Hotel by clicking here. Room block with discounted rates expires on August 27, 2018.

By registering for this conference, you are granting permission for your contact information to be shared with North Carolina Public Health, NCPH, which is a joint provider of this continuing education activity. 

Objectives

  • Describe the current epidemiological landscape of the infectious implications of drug use in North Carolina
  • Discuss three different ways a patient may use drugs and describe how to develop a treatment plan with that mechanism of use in mind
  • Identify and develop collaborations with other area providers working with drug users along the spectrum of care
  • Develop clinic practices that promote a nonjudgmental clinical atmosphere that actively engages and retains in care patients who use drugs

Click here for program brochure

Sep
28
Fri
Recovery Within Reach: Building Team Expertise in Office Based Opioid Treatment (OBOT) @ Mountain Area Health Education Center, Pisgah Room
Sep 28 @ 8:30 am – 12:45 pm

18MH032 - Recovery Within Reach: Building Team Expertise in Office Based Opioid Treatment (OBOT)

There are two dates to select from for this event: June 22 and September 28

Intended Audience is Mental health professionals (including substance abuse counselors, social workers, school counselors, psychologists, marriage and family therapists), nurses, practice managers, program administrators, medical assistants, care managers, care coordinators and other professionals interested in this subject.

Opioid addiction is a chronic, relapsing brain disease that affects millions of Americans and produces tremendous burden on the healthcare system. In 2002, U.S. physicians gained the opportunity to treat opioid-addicted patients with buprenorphine in primary care settings, commonly referred to as office-based opioid treatment (OBOT). OBOT has been shown to be effective in primary care settings and impacts public health through the reduction of opioid use, opioid overdose mortality and transmission of infectious diseases. However, it remains underutilized.

One consistently cited barrier preventing OBOT expansion is lack of adequate clinical support given the additional needs for patient monitoring. Successful medication assisted treatment (MAT) requires a team-based approach just like treatment for other chronic diseases. In addition, treatment is more effective when providers can use a trauma-informed and gender-responsive treatment plan.

The goal of this companion program to the AAAP Clinical Support System—Buprenorphine Office Based Treatment for Opioid Use Disorders (The “Half and Half” Course)—is to increase comfort level and expertise of the healthcare team by outlining a team approach, trauma-informed interventions, gender-responsive care and recommendations for the implementation of buprenorphine OBOT.

Click here for a program brochure

Click here for registration

Providers’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course @ Mountain Area Health Education Center, Pisgah Room
Sep 28 @ 1:30 pm – 6:00 pm

18ME047 - Providers’ Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders, The “Half and Half” Course

There are two dates to select from for this event: June 22 and September 28

The program is recommended for prescribers in primary care, emergency medicine, pain management, psychiatric, HIV and addiction medicine.

Opioid dependence is epidemic in the United States. While progress has been made in training providers, the gap in providing effective treatment of opioid use disorders continues to widen, moving beyond heroin addicted individuals to a much larger and diverse segment of the population. This increase is predominantly due to an alarming increase in addiction to prescription opioid analgesic medications.

Buprenorphine, the most recent addition to the pharmacotherapies available to treat opioid dependence, is novel among the opioid pharmacotherapies because of its partial agonist properties. It has been placed on Schedule III and is available by prescription from a physician’s office-based practice.

Recognizing the impact of this addiction, as well as learning how to treat opioid use disorders, are important steps in combating this ever growing medical problem. To obtain the waiver to prescribe, providers are required to take specialized training. PCSS-MAT uses the Half-and-Half format (4.25 hours of face-to-face training with an instructor, followed by 3.75 hours of on-your-own-training that must be completed along with a post test). This training meets the requirements for physicians; however additional training is required for advanced practice providers.

The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. Once the waiver training is completed in full, participants will receive a CME certificate of attendance from AAAP.

Click here for registration

Click here for a PDF brochure

Oct
4
Thu
The 4th Annual Western North Carolina Rural Health Symposium: Challenges, Successes and Strategies @ Blue Ridge Room
Oct 4 @ 8:00 am – Oct 5 @ 4:30 pm

Image result for mahec

Save the date! Registration opens soon.

Rural communities in Western North Carolina – and across America – face many challenges including the opioid crisis, food insecurity, aging populations, chronic diseases, limited resources and reduced access to healthcare due to workforce shortages. Please join us to learn more about how these issues are impacting WNC, and how innovative, collaborative approaches and strategies are being used to combat these problems to build resiliency among individuals and throughout communities.

Hotel Accommodations
A block of rooms has been reserved for October 3, 2018 – October 5, 2018. The special room rate will be available until September 3rd or until the group block is sold-out, whichever comes first. To book a room, please click here for the Hampton Inn.

Target Audience

This conference will be of interest to physicians, nurse practitioners, physician assistants, pharmacists, nurses, mental health professionals, social workers, integrated healthcare professionals, public health professionals, and all healthcare professionals working with patients and their families in rural areas.

Objectives

  • Recognize how social determinants effect health and cite strategies being used in rural WNC to improve health outcomes
  • Describe how WNC communities are addressing common health challenges such as aging, opioid misuse and workforce shortages
  • Identify strategies to promote individual and community wide resilience
  • Learn and integrate novel technologies to meet health care needs in rural communities

Sessions

19ME012 – The 4th Annual Western North Carolina Rural Health Symposium: Challenges, Successes and Strategies – DAY ONE – Thursday
10/4 8:00 AM–4:30 PM
19ME012 – The 4th Annual Western North Carolina Rural Health Symposium: Challenges, Successes and Strategies – DAY TWO – Friday
10/5 8:00 AM–4:30 PM